1.A Case of Huge Retroperitoneal Cystic Mesothelioma Mimicking Diffuse Ascites
Ha Young KIM ; Joseph AHN ; Eun Mee HAN ; Jun-young SEO
Clinical Ultrasound 2024;9(2):85-90
		                        		
		                        			
		                        			 A 42-year-old female patient was found to have a lesion that appeared to be ascites during a trans-abdominal ultrasound at a local healthcare center as part of a routine health check-up. She was subsequently referred to the gastroenterology department of Bundang Jesaeng General Hospital for further evaluation. Abdomino-pelvic computed tomography (CT) and magnetic resonance imaging (MRI) revealed a cystic lesion suspected to be a retroperitoneal lymphangioma. The patient underwent laparoscopic resection based on these findings, and a postoperative pathological examination confirmed the diagnosis of cystic mesothelioma. She has been followed for 5 months after surgery without any complications or signs of recurrence. When a localized lesion resembling ascites is found in a patient without underlying conditions, it is important to include cystic tumor in the differential diagnosis. Comprehensive imaging studies like CT and MRI, along with surgical intervention and immunohistochemical analysis, are crucial for accurate diagnosis and treatment. 
		                        		
		                        		
		                        		
		                        	
2.Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality
Thanh N. NGUYEN ; Muhammad M. QURESHI ; Piers KLEIN ; Hiroshi YAMAGAMI ; Mohamad ABDALKADER ; Robert MIKULIK ; Anvitha SATHYA ; Ossama Yassin MANSOUR ; Anna CZLONKOWSKA ; Hannah LO ; Thalia S. FIELD ; Andreas CHARIDIMOU ; Soma BANERJEE ; Shadi YAGHI ; James E. SIEGLER ; Petra SEDOVA ; Joseph KWAN ; Diana Aguiar DE SOUSA ; Jelle DEMEESTERE ; Violiza INOA ; Setareh Salehi OMRAN ; Liqun ZHANG ; Patrik MICHEL ; Davide STRAMBO ; João Pedro MARTO ; Raul G. NOGUEIRA ; ; Espen Saxhaug KRISTOFFERSEN ; Georgios TSIVGOULIS ; Virginia Pujol LEREIS ; Alice MA ; Christian ENZINGER ; Thomas GATTRINGER ; Aminur RAHMAN ; Thomas BONNET ; Noémie LIGOT ; Sylvie DE RAEDT ; Robin LEMMENS ; Peter VANACKER ; Fenne VANDERVORST ; Adriana Bastos CONFORTO ; Raquel C.T. HIDALGO ; Daissy Liliana MORA CUERVO ; Luciana DE OLIVEIRA NEVES ; Isabelle LAMEIRINHAS DA SILVA ; Rodrigo Targa MARTÍNS ; Letícia C. REBELLO ; Igor Bessa SANTIAGO ; Teodora SADELAROVA ; Rosen KALPACHKI ; Filip ALEXIEV ; Elena Adela CORA ; Michael E. KELLY ; Lissa PEELING ; Aleksandra PIKULA ; Hui-Sheng CHEN ; Yimin CHEN ; Shuiquan YANG ; Marina ROJE BEDEKOVIC ; Martin ČABAL ; Dusan TENORA ; Petr FIBRICH ; Pavel DUŠEK ; Helena HLAVÁČOVÁ ; Emanuela HRABANOVSKA ; Lubomír JURÁK ; Jana KADLČÍKOVÁ ; Igor KARPOWICZ ; Lukáš KLEČKA ; Martin KOVÁŘ ; Jiří NEUMANN ; Hana PALOUŠKOVÁ ; Martin REISER ; Vladimir ROHAN ; Libor ŠIMŮNEK ; Ondreij SKODA ; Miroslav ŠKORŇA ; Martin ŠRÁMEK ; Nicolas DRENCK ; Khalid SOBH ; Emilie LESAINE ; Candice SABBEN ; Peggy REINER ; Francois ROUANET ; Daniel STRBIAN ; Stefan BOSKAMP ; Joshua MBROH ; Simon NAGEL ; Michael ROSENKRANZ ; Sven POLI ; Götz THOMALLA ; Theodoros KARAPANAYIOTIDES ; Ioanna KOUTROULOU ; Odysseas KARGIOTIS ; Lina PALAIODIMOU ; José Dominguo BARRIENTOS GUERRA ; Vikram HUDED ; Shashank NAGENDRA ; Chintan PRAJAPATI ; P.N. SYLAJA ; Achmad Firdaus SANI ; Abdoreza GHOREISHI ; Mehdi FARHOUDI ; Elyar SADEGHI HOKMABADI ; Mazyar HASHEMILAR ; Sergiu Ionut SABETAY ; Fadi RAHAL ; Maurizio ACAMPA ; Alessandro ADAMI ; Marco LONGONI ; Raffaele ORNELLO ; Leonardo RENIERI ; Michele ROMOLI ; Simona SACCO ; Andrea SALMAGGI ; Davide SANGALLI ; Andrea ZINI ; Kenichiro SAKAI ; Hiroki FUKUDA ; Kyohei FUJITA ; Hirotoshi IMAMURA ; Miyake KOSUKE ; Manabu SAKAGUCHI ; Kazutaka SONODA ; Yuji MATSUMARU ; Nobuyuki OHARA ; Seigo SHINDO ; Yohei TAKENOBU ; Takeshi YOSHIMOTO ; Kazunori TOYODA ; Takeshi UWATOKO ; Nobuyuki SAKAI ; Nobuaki YAMAMOTO ; Ryoo YAMAMOTO ; Yukako YAZAWA ; Yuri SUGIURA ; Jang-Hyun BAEK ; Si Baek LEE ; Kwon-Duk SEO ; Sung-Il SOHN ; Jin Soo LEE ; Anita Ante ARSOVSKA ; Chan Yong CHIEH ; Wan Asyraf WAN ZAIDI ; Wan Nur Nafisah WAN YAHYA ; Fernando GONGORA-RIVERA ; Manuel MARTINEZ-MARINO ; Adrian INFANTE-VALENZUELA ; Diederik DIPPEL ; Dianne H.K. VAN DAM-NOLEN ; Teddy Y. WU ; Martin PUNTER ; Tajudeen Temitayo ADEBAYO ; Abiodun H. BELLO ; Taofiki Ajao SUNMONU ; Kolawole Wasiu WAHAB ; Antje SUNDSETH ; Amal M. AL HASHMI ; Saima AHMAD ; Umair RASHID ; Liliana RODRIGUEZ-KADOTA ; Miguel Ángel VENCES ; Patrick Matic YALUNG ; Jon Stewart Hao DY ; Waldemar BROLA ; Aleksander DĘBIEC ; Malgorzata DOROBEK ; Michal Adam KARLINSKI ; Beata M. LABUZ-ROSZAK ; Anetta LASEK-BAL ; Halina SIENKIEWICZ-JAROSZ ; Jacek STASZEWSKI ; Piotr SOBOLEWSKI ; Marcin WIĄCEK ; Justyna ZIELINSKA-TUREK ; André Pinho ARAÚJO ; Mariana ROCHA ; Pedro CASTRO ; Patricia FERREIRA ; Ana Paiva NUNES ; Luísa FONSECA ; Teresa PINHO E MELO ; Miguel RODRIGUES ; M Luis SILVA ; Bogdan CIOPLEIAS ; Adela DIMITRIADE ; Cristian FALUP-PECURARIU ; May Adel HAMID ; Narayanaswamy VENKETASUBRAMANIAN ; Georgi KRASTEV ; Jozef HARING ; Oscar AYO-MARTIN ; Francisco HERNANDEZ-FERNANDEZ ; Jordi BLASCO ; Alejandro RODRÍGUEZ-VÁZQUEZ ; Antonio CRUZ-CULEBRAS ; Francisco MONICHE ; Joan MONTANER ; Soledad PEREZ-SANCHEZ ; María Jesús GARCÍA SÁNCHEZ ; Marta GUILLÁN RODRÍGUEZ ; Gianmarco BERNAVA ; Manuel BOLOGNESE ; Emmanuel CARRERA ; Anchalee CHUROJANA ; Ozlem AYKAC ; Atilla Özcan ÖZDEMIR ; Arsida BAJRAMI ; Songul SENADIM ; Syed I. HUSSAIN ; Seby JOHN ; Kailash KRISHNAN ; Robert LENTHALL ; Kaiz S. ASIF ; Kristine BELOW ; Jose BILLER ; Michael CHEN ; Alex CHEBL ; Marco COLASURDO ; Alexandra CZAP ; Adam H. DE HAVENON ; Sushrut DHARMADHIKARI ; Clifford J. ESKEY ; Mudassir FAROOQUI ; Steven K. FESKE ; Nitin GOYAL ; Kasey B. GRIMMETT ; Amy K. GUZIK ; Diogo C. HAUSSEN ; Majesta HOVINGH ; Dinesh JILLELA ; Peter T. KAN ; Rakesh KHATRI ; Naim N. KHOURY ; Nicole L. KILEY ; Murali K. KOLIKONDA ; Stephanie LARA ; Grace LI ; Italo LINFANTE ; Aaron I. LOOCHTAN ; Carlos D. LOPEZ ; Sarah LYCAN ; Shailesh S. MALE ; Fadi NAHAB ; Laith MAALI ; Hesham E. MASOUD ; Jiangyong MIN ; Santiago ORGETA-GUTIERREZ ; Ghada A. MOHAMED ; Mahmoud MOHAMMADEN ; Krishna NALLEBALLE ; Yazan RADAIDEH ; Pankajavalli RAMAKRISHNAN ; Bliss RAYO-TARANTO ; Diana M. ROJAS-SOTO ; Sean RULAND ; Alexis N. SIMPKINS ; Sunil A. SHETH ; Amy K. STAROSCIAK ; Nicholas E. TARLOV ; Robert A. TAYLOR ; Barbara VOETSCH ; Linda ZHANG ; Hai Quang DUONG ; Viet-Phuong DAO ; Huynh Vu LE ; Thong Nhu PHAM ; Mai Duy TON ; Anh Duc TRAN ; Osama O. ZAIDAT ; Paolo MACHI ; Elisabeth DIRREN ; Claudio RODRÍGUEZ FERNÁNDEZ ; Jorge ESCARTÍN LÓPEZ ; Jose Carlos FERNÁNDEZ FERRO ; Niloofar MOHAMMADZADEH ; Neil C. SURYADEVARA, MD ; Beatriz DE LA CRUZ FERNÁNDEZ ; Filipe BESSA ; Nina JANCAR ; Megan BRADY ; Dawn SCOZZARI
Journal of Stroke 2022;24(2):256-265
		                        		
		                        			 Background:
		                        			and Purpose Recent studies suggested an increased incidence of cerebral venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We evaluated the volume of CVT hospitalization and in-hospital mortality during the 1st year of the COVID-19 pandemic compared to the preceding year. 
		                        		
		                        			Methods:
		                        			We conducted a cross-sectional retrospective study of 171 stroke centers from 49 countries. We recorded COVID-19 admission volumes, CVT hospitalization, and CVT in-hospital mortality from January 1, 2019, to May 31, 2021. CVT diagnoses were identified by International Classification of Disease-10 (ICD-10) codes or stroke databases. We additionally sought to compare the same metrics in the first 5 months of 2021 compared to the corresponding months in 2019 and 2020 (ClinicalTrials.gov Identifier: NCT04934020). 
		                        		
		                        			Results:
		                        			There were 2,313 CVT admissions across the 1-year pre-pandemic (2019) and pandemic year (2020); no differences in CVT volume or CVT mortality were observed. During the first 5 months of 2021, there was an increase in CVT volumes compared to 2019 (27.5%; 95% confidence interval [CI], 24.2 to 32.0; P<0.0001) and 2020 (41.4%; 95% CI, 37.0 to 46.0; P<0.0001). A COVID-19 diagnosis was present in 7.6% (132/1,738) of CVT hospitalizations. CVT was present in 0.04% (103/292,080) of COVID-19 hospitalizations. During the first pandemic year, CVT mortality was higher in patients who were COVID positive compared to COVID negative patients (8/53 [15.0%] vs. 41/910 [4.5%], P=0.004). There was an increase in CVT mortality during the first 5 months of pandemic years 2020 and 2021 compared to the first 5 months of the pre-pandemic year 2019 (2019 vs. 2020: 2.26% vs. 4.74%, P=0.05; 2019 vs. 2021: 2.26% vs. 4.99%, P=0.03). In the first 5 months of 2021, there were 26 cases of vaccine-induced immune thrombotic thrombocytopenia (VITT), resulting in six deaths.  
		                        		
		                        			Conclusions
		                        			During the 1st year of the COVID-19 pandemic, CVT hospitalization volume and CVT in-hospital mortality did not change compared to the prior year. COVID-19 diagnosis was associated with higher CVT in-hospital mortality. During the first 5 months of 2021, there was an increase in CVT hospitalization volume and increase in CVT-related mortality, partially attributable to VITT. 
		                        		
		                        		
		                        		
		                        	
3.Survival Effects of Cytoreductive Surgery for Refractory Patients after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer
Wonkyo SHIN ; Joseph J. NOH ; Sang-Soo SEO ; Sokbom KANG ; Chel-Hun CHOI ; Sang-Yoon PARK ; Byoung-Gie KIM ; Myong Cheol LIM
Yonsei Medical Journal 2020;61(11):935-941
		                        		
		                        			 Purpose:
		                        			Salvage second-line chemotherapy is usually recommended for patients with advanced epithelial ovarian cancer (AEOC) who develop progressive disease (PD) after neoadjuvant chemotherapy (NAC). Herein, we investigated the role of cytoreductive surgery (CRS) for such patients. 
		                        		
		                        			Materials and Methods:
		                        			We retrospectively reviewed the medical records of 36 patients with AEOC who developed PD after receiving NAC at two tertiary academic centers with different treatment strategies between 2001 and 2016. Patients who developed PD after NAC were consistently treated with CRS at one hospital (group A; n=13) and second-line chemotherapy at another (group B;n=23). The clinical characteristics and treatment outcomes were compared between the groups. 
		                        		
		                        			Results:
		                        			Overall survival (OS) was longer in group A than in group B (19.4 months vs. 7.9 months; p=0.011). High-grade serous histology was associated with longer OS than non-high-grade serous types. In group A, optimal surgery resection (<1 cm) was achieved after CRS in 6 patients (46%). Multivariate analysis showed that the treatment option was the only independent predictive factor for OS (hazard ratio, 2.30; 95% confidence interval, 1.02–5.17; p=0.044). 
		                        		
		                        			Conclusion
		                        			CRS may result in a survival benefit even in patients with AEOC who develop PD after NAC. 
		                        		
		                        		
		                        		
		                        	
4.Isolation of Secretome with Enhanced Antifibrotic Properties from miR-214-Transfected Adipose-Derived Stem Cells
Jung Hyun PARK ; Ok Hee KIM ; Kee Hwan KIM ; Ha Eun HONG ; Haeyeon SEO ; Ho Joong CHOI ; Joseph AHN ; Tae Yun LEE ; Say June KIM
Journal of Korean Medical Science 2019;34(45):e273-
		                        		
		                        			
		                        			BACKGROUND: Secretome refers to the total set of molecules secreted or surface-shed by stem cells. The limitations of stem cell research have led numerous investigators to turn their attention to the use of secretome instead of stem cells. In this study, we intended to reinforce antifibrotic properties of the secretome released from adipose-derived stem cells (ASCs) transfected with miR-214. METHODS: We generated miR-214-transfected ASCs, and extracted the secretome (miR214-secretome) from conditioned media of the transfected ASCs through a series of ultrafiltrations. Subsequently, we intravenously injected the miR-214-secretome into mice with liver fibrosis, and determined the effects of miR-214-secretome on liver fibrosis. RESULTS: Compared with that by naïve secretome, liver fibrosis was ameliorated by intravenous infusion of miR-214-secretome into mice with liver fibrosis, which was demonstrated by significantly lower expression of fibrosis-related markers (alpha-smooth muscle actin, transforming growth factor-β, and metalloproteinases-2) in the livers as well as lower fibrotic scores in the special stained livers compared with naïve secretome. The infusion of miR-214-secretome also led to lesser local and systemic inflammation, higher expression of an antioxidant enzyme (superoxide dismutase), and higher liver proliferative and synthetic function. CONCLUSION: MicroRNA-214 transfection stimulates ASCs to release the secretome with higher antifibrotic and anti-inflammatory properties. miR-214-secretome is thus expected to be one of the prominent ways of overcoming liver fibrosis, if further studies consistently validate its safety and efficiency.
		                        		
		                        		
		                        		
		                        			Actins
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Culture Media, Conditioned
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Inflammation
		                        			;
		                        		
		                        			Infusions, Intravenous
		                        			;
		                        		
		                        			Liver
		                        			;
		                        		
		                        			Liver Cirrhosis
		                        			;
		                        		
		                        			Mesenchymal Stromal Cells
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			MicroRNAs
		                        			;
		                        		
		                        			Research Personnel
		                        			;
		                        		
		                        			Stem Cell Research
		                        			;
		                        		
		                        			Stem Cells
		                        			;
		                        		
		                        			Transfection
		                        			
		                        		
		                        	
5.Corrigendum: Elucidation of Bacterial Pneumonia-Causing Pathogens in Patients with Respiratory Viral Infection.
Hwa Sik JUNG ; Byung Ju KANG ; Seung Won RA ; Kwang Won SEO ; Yangjin JEGAL ; Jae Bum JUN ; Jiwon JUNG ; Joseph JEONG ; Hee Jeong JEON ; Jae Sung AHN ; Taehoon LEE ; Jong Joon AHN
Tuberculosis and Respiratory Diseases 2018;81(4):349-349
		                        		
		                        			
		                        			In this article, the ethical statement was missing.
		                        		
		                        		
		                        		
		                        	
6.Elucidation of Bacterial Pneumonia-Causing Pathogens in Patients with Respiratory Viral Infection.
Hwa Sik JUNG ; Byung Ju KANG ; Seung Won RA ; Kwang Won SEO ; Yangjin JEGAL ; Jae Bum JUN ; Jiwon JUNG ; Joseph JEONG ; Hee Jeong JEON ; Jae Sung AHN ; Taehoon LEE ; Jong Joon AHN
Tuberculosis and Respiratory Diseases 2017;80(4):358-367
		                        		
		                        			
		                        			BACKGROUND: Bacterial pneumonia occurring after respiratory viral infection is common. However, the predominant bacterial species causing pneumonia secondary to respiratory viral infections other than influenza remain unknown. The purpose of this study was to know whether the pathogens causing post-viral bacterial pneumonia vary according to the type of respiratory virus. METHODS: Study subjects were 5,298 patients, who underwent multiplex real-time polymerase chain reaction for simultaneous detection of respiratory viruses, among who visited the emergency department or outpatient clinic with respiratory symptoms at Ulsan University Hospital between April 2013 and March 2016. The patients' medical records were retrospectively reviewed. RESULTS: A total of 251 clinically significant bacteria were identified in 233 patients with post-viral bacterial pneumonia. Mycoplasma pneumoniae was the most frequent bacterium in patients aged <16 years, regardless of the preceding virus type (p=0.630). In patients aged ≥16 years, the isolated bacteria varied according to the preceding virus type. The major results were as follows (p<0.001): pneumonia in patients with influenza virus (type A/B), rhinovirus, and human metapneumovirus infections was caused by similar bacteria, and the findings indicated that Staphylococcus aureus pneumonia was very common in these patients. In contrast, coronavirus, parainfluenza virus, and respiratory syncytial virus infections were associated with pneumonia caused by gram-negative bacteria. CONCLUSION: The pathogens causing post-viral bacterial pneumonia vary according to the type of preceding respiratory virus. This information could help in selecting empirical antibiotics in patients with post-viral pneumonia.
		                        		
		                        		
		                        		
		                        			Ambulatory Care Facilities
		                        			;
		                        		
		                        			Anti-Bacterial Agents
		                        			;
		                        		
		                        			Bacteria
		                        			;
		                        		
		                        			Coronavirus
		                        			;
		                        		
		                        			Emergency Service, Hospital
		                        			;
		                        		
		                        			Gram-Negative Bacteria
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Influenza, Human
		                        			;
		                        		
		                        			Medical Records
		                        			;
		                        		
		                        			Metapneumovirus
		                        			;
		                        		
		                        			Mycoplasma pneumoniae
		                        			;
		                        		
		                        			Orthomyxoviridae
		                        			;
		                        		
		                        			Paramyxoviridae Infections
		                        			;
		                        		
		                        			Pneumonia
		                        			;
		                        		
		                        			Pneumonia, Bacterial
		                        			;
		                        		
		                        			Pneumonia, Mycoplasma
		                        			;
		                        		
		                        			Pneumonia, Staphylococcal
		                        			;
		                        		
		                        			Real-Time Polymerase Chain Reaction
		                        			;
		                        		
		                        			Respiratory Syncytial Virus Infections
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Rhinovirus
		                        			;
		                        		
		                        			Ulsan
		                        			
		                        		
		                        	
7.Directing Human Embryonic Stem Cells towards Functional Endothelial Cells Easily and without Purification.
Chang Hyun GIL ; Byeong Seong KI ; Joseph SEO ; Jong Jin CHOI ; Hana KIM ; In Gul KIM ; A Ra JUNG ; Won Young LEE ; Youngsok CHOI ; Kwideok PARK ; Sung Hwan MOON ; Hyung Min CHUNG
Tissue Engineering and Regenerative Medicine 2016;13(3):274-283
		                        		
		                        			
		                        			Hemangioblasts or blood islands only arise in early development thereby the sources to obtain these bi-potential cells are limited. While previous studies have isolated both lineages in vitro through the hemangioblast, derivation efficiency was rather low due to cellular damage attributed by enzyme usage and fluorescent activated cell sorting (FACS). This study focused on avoiding the use of damaging factors in the derivation of endothelial cells (ECs). Single cell H9-human embryonic stem cells (hESCs) were obtained by using a mild dissociation protocol then human embryoid body (hEB) formation was performed under hemangioblast differentiation conditions. The hEBs were subjected to a two-stage cytokine treatment procedure. Subsequent culture of the adhesive cells in day 4 hEBs gave arise to a seemingly pure population of ECs. The hESC-derived ECs were characterized by identifying signature endothelial gene and protein markers as well as testing for in vitro functionality. Furthermore, in vivo functionality was also confirmed by transplanting the cells in hindlimb ischemic murine models. We demonstrate that the genetic change required for EC derivation precedes blast colony formation. Furthermore, cell damage was prevented by abating enzyme usage and FACS, resulting in a high yield of ECs upon adhesion. Under this method, confluent cultures of ECs were obtainable 4 days after hEB formation which is significantly faster than previous protocols.
		                        		
		                        		
		                        		
		                        			Adhesives
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Embryoid Bodies
		                        			;
		                        		
		                        			Embryonic Stem Cells
		                        			;
		                        		
		                        			Endothelial Cells*
		                        			;
		                        		
		                        			Hemangioblasts
		                        			;
		                        		
		                        			Hindlimb
		                        			;
		                        		
		                        			Human Embryonic Stem Cells*
		                        			;
		                        		
		                        			Humans*
		                        			;
		                        		
		                        			In Vitro Techniques
		                        			;
		                        		
		                        			Islands
		                        			;
		                        		
		                        			Methods
		                        			
		                        		
		                        	
8.A Case of Acute Cholecystitis Combined with Eosinophilic Pericarditis Caused by Toxocariasis.
Jin Woo CHOO ; Hyun Jong CHOI ; Jong Ho MOON ; Jong Ho CHUNG ; Jin Seok PARK ; Yu Sik MYUNG ; Hye Sun SEO
Korean Journal of Medicine 2013;84(6):836-841
		                        		
		                        			
		                        			Toxocariasis is a parasite infection of a human host caused by Toxocara canis. Most human infections occur in persons who eat contaminated food containing embryonated eggs or larvae. Toxocariasis can produce various symptoms associated with eosinophilic infiltration into various internal organs such as the liver, lungs, eyes, or central nervous system. However, a simultaneous onset of cholecystitis and pericarditis has not yet been reported in the literature. A 39-year-old female patient complained of right upper abdominal pain. Several imaging studies revealed acute cholecystitis and pericarditis with pericardial effusion. Marked eosinophilia was observed in her peripheral blood and pericardial fluid. A high titer of antibodies against T. canis was discovered during the search for the cause of the eosinophilia. All clinical features and the eosinophilia improved dramatically after treatment with albendazole. We report a case of simultaneous onset of acute cholecystitis and pericarditis associated with marked eosinophilia caused by T. canis.
		                        		
		                        		
		                        		
		                        			Abdominal Pain
		                        			;
		                        		
		                        			Albendazole
		                        			;
		                        		
		                        			Antibodies
		                        			;
		                        		
		                        			Central Nervous System
		                        			;
		                        		
		                        			Cholecystitis
		                        			;
		                        		
		                        			Cholecystitis, Acute
		                        			;
		                        		
		                        			Eggs
		                        			;
		                        		
		                        			Eosinophilia
		                        			;
		                        		
		                        			Eosinophils
		                        			;
		                        		
		                        			Eye
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Larva
		                        			;
		                        		
		                        			Liver
		                        			;
		                        		
		                        			Lung
		                        			;
		                        		
		                        			Ovum
		                        			;
		                        		
		                        			Parasites
		                        			;
		                        		
		                        			Pericardial Effusion
		                        			;
		                        		
		                        			Pericarditis
		                        			;
		                        		
		                        			Toxocara canis
		                        			;
		                        		
		                        			Toxocariasis
		                        			
		                        		
		                        	
9.The Combination of Real-Time PCR and HPLC for the Identification of Non-Tuberculous Mycobacteria.
Jae Sun PARK ; Jung In CHOI ; Ji Hun LIM ; Jong Joon AHN ; Yangjin JEGAL ; Kwang Won SEO ; Seung Won RA ; Jae Bum JEON ; Seon Ho LEE ; Sung Ryul KIM ; Joseph JEONG
Annals of Laboratory Medicine 2013;33(5):349-352
		                        		
		                        			
		                        			We used HPLC and AdvanSure real-time PCR (LG Life Sciences, Korea) to retrospectively analyze non-tuberculous mycobacteria (NTM) in 133 clinical specimens. The specimens were culture-positive for NTM and the HPLC method identified 130 strains of mycobacteria from the cultures (97.7%) at the species level. Among the isolates, 48 Mycobacterium. kansasii (36.1%), 39 M. intracellulare (29.3%), 17 M. avium (12.8%), 16 M. abscessus (12.0%), 6 M. fortuitum (4.5%), 2 M. szulgai (1.5%), 2 M. gordonae (1.5%), and 3 unclassified NTM strains (2.3%) were identified. The real-time PCR assay identified 60 NTM-positive specimens (45.1%), 65 negative specimens (48.9%), and 8 M. tuberculosis (TB)-positive specimens (6.0%). The real-time PCR assay is advantageous because of its rapid identification of NTM. However, in our study, the real-time PCR assay showed relatively low sensitivity (45.1%) when using direct specimens including sputum and bronchoalveolar lavage (BAL) fluid. HPLC is useful as it discriminates NTM at the species level, although it is time-consuming and requires specific equipment and technical expertise. A combination of both methods will be helpful for the rapid and accurate identification of mycobacteria in clinical laboratories.
		                        		
		                        		
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Aged, 80 and over
		                        			;
		                        		
		                        			Bronchoalveolar Lavage Fluid/microbiology
		                        			;
		                        		
		                        			*Chromatography, High Pressure Liquid
		                        			;
		                        		
		                        			DNA, Bacterial/genetics
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Mycobacterium/*genetics/isolation & purification
		                        			;
		                        		
		                        			Mycobacterium Infections/diagnosis/*microbiology
		                        			;
		                        		
		                        			*Real-Time Polymerase Chain Reaction
		                        			;
		                        		
		                        			Sputum/microbiology
		                        			
		                        		
		                        	
10.Lung Infection Caused by Mycobacterium riyadhense Confused with Mycobacterium tuberculosis: The First Case in Korea.
Jung In CHOI ; Ji Hun LIM ; Sung Ryul KIM ; Seon Ho LEE ; Jae Sun PARK ; Kwang Won SEO ; Jae Bum JEON ; Joseph JEONG
Annals of Laboratory Medicine 2012;32(4):298-303
		                        		
		                        			
		                        			A slowly growing, non-chromogenic mycobacterial strain was isolated from sputum and bronchial lavage fluid samples of a patient presenting with productive cough, blood-tinged sputum, low-grade fever, and weakness. A positive acid-fast bacilli sputum smear result prompted the initiation of an anti-tuberculosis regimen. Multiplex real-time PCR showed a negative result for Mycobacterium tuberculosis complex and a positive result for nontuberculous mycobacteria. The DNA chip test confirmed this organism as a member of the genus Mycobacterium, but could not specify the species. Interestingly, the mycolic acid patterns obtained by HPLC nearly overlapped with those of M. simulans. The sequences of the Mycobacterium 16S rRNA gene and 16S-23S internal transcribed spacer region were unique and were found to have 100% similarity with those of M. riyadhense. After a review of the literature, we report this case as the first Korean case of M. riyadhense lung infection.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Antitubercular Agents/pharmacology
		                        			;
		                        		
		                        			Chromatography, High Pressure Liquid
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Lung Diseases/*microbiology
		                        			;
		                        		
		                        			Microbial Sensitivity Tests
		                        			;
		                        		
		                        			Mycobacterium/classification/drug effects/*isolation & purification
		                        			;
		                        		
		                        			Mycobacterium Infections/microbiology
		                        			;
		                        		
		                        			Mycobacterium tuberculosis/genetics/isolation & purification
		                        			;
		                        		
		                        			Mycolic Acids/analysis
		                        			;
		                        		
		                        			Oligonucleotide Array Sequence Analysis
		                        			;
		                        		
		                        			Phylogeny
		                        			;
		                        		
		                        			RNA, Ribosomal, 16S/chemistry/genetics
		                        			;
		                        		
		                        			RNA, Ribosomal, 23S/chemistry/genetics
		                        			;
		                        		
		                        			Republic of Korea
		                        			;
		                        		
		                        			Sequence Analysis, DNA
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail